Want to join the conversation?
$PFE's research and development expenses for 2015 slid by 8% from last year. This decline was primarily due to non-recurrence of a charge associated with a collaborative arrangement with Merck, lower clinical trial expenses for various studies, lower upfront payments, and the favorable impact of foreign exchange of 2%.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.